Drug counterfeiting has become a major problem for the FDA today; a variety of solutions is needed.
Eric Hargan
Advertisement
Eric Hargan is a partner and a member of the health law department in the law firm of McDermott Will & Emery LLP
Articles by Eric Hargan
Advertisement
Latest Updated Articles
Faking ItPublished: December 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Everything to Know About Cell and Gene Therapy in 2025
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
5
